Ramu A, Shan T C, Glaubiger D
Cancer Treat Rep. 1983 Oct;67(10):895-9.
Acquired resistance to doxorubicin in a P388 murine leukemia cell subline was found to be associated with decreased drug accumulation in these cells. We have previously shown that the lipid domain of the plasma membrane in drug-resistant cells is structurally more ordered and has a lower phosphatidylcholine/sphingomyelin ratio. Perhexiline maleate and triparanol both markedly enhance the sensitivity of drug-resistant cells to doxorubicin and vinblastine but do not have an effect on anthracycline-sensitive cells. This enhanced sensitivity is associated with increased drug accumulation. Although perhexiline maleate has been reported to be a calcium antagonist in other systems, our data do not implicate this mechanism in the enhancement of cell sensitivity to doxorubicin. We suggest that this effect might be related to alterations of the cell membrane lipid domain induced by perhexiline maleate and triparanol, which result in decreased structural order of plasma membrane lipids and permit increased drug accumulation.
在一个P388小鼠白血病细胞亚系中发现,对阿霉素产生的获得性耐药与这些细胞中药物积累的减少有关。我们之前已经表明,耐药细胞中质膜的脂质结构域在结构上更有序,且磷脂酰胆碱/鞘磷脂的比例更低。马来酸哌克昔林和曲帕拉醇均能显著增强耐药细胞对阿霉素和长春碱的敏感性,但对蒽环类药物敏感细胞没有影响。这种增强的敏感性与药物积累增加有关。尽管马来酸哌克昔林在其他系统中被报道为钙拮抗剂,但我们的数据并未表明该机制与细胞对阿霉素敏感性的增强有关。我们认为,这种效应可能与马来酸哌克昔林和曲帕拉醇诱导的细胞膜脂质结构域的改变有关,这导致质膜脂质的结构有序性降低,并使药物积累增加。